University Hospitals-Cleveland

Cleveland, Ohio 44106

9 studies enrolling now · 25 studies all time

What they study most

1st Line NSCLC, Abdominal Aortic Aneurysm, Advanced Solid Tumor, Ascending Aorta Aneurysm, Ascending Aortic Aneurysm Enlargement, Benign Prostatic Hyperplasia, Bilateral Hearing Loss, Blood Cancer, Breast Cancer, COVID-19, Carcinoma, Hepatocellular, Cardiac Valve Disease

Studies at this site

• Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers — Recruiting now
• Sacral Neuromodulation for Male Overactive Bladder (MOAB) — Recruiting now
• Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array — Recruiting now
• Nectero EAST System Clinical Study — Recruiting now
• Medtronic Cardiac Surgery PMCF Registry — Recruiting now
• The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study — Recruiting now
• Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance — Recruiting now
• IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers — Recruiting now
• CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting — Recruiting now
• Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC — Stopped early
• ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation — Completed
• Biodesign® Otologic Repair Graft — Completed
• Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes — Completed
• Pivotal Omnipod Horizon™ Automated Glucose Control System — Completed
• Study of a Gene Therapy Treatment for Hemophilia A — Withdrawn before enrolling
• Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease — Stopped early
• SCOPE CLI (Shifting Care and Outcomes for Patients With Endangered Limbs - Critical Limb Ischemia) — Completed
• Omnipod Horizon™ Automated Glucose Control System Preschool Cohort — Completed
• A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) — Stopped early
• Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures — Completed
• Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) — Stopped early
• SHIELD II Clinical Investigation — Stopped early
• A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) — Completed
• REPLACE: Implantable Cardiac Pulse Generator Replacement Registry — Completed
• Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes — Completed